Search research articles
Contact Us
Filters
Showing results (551-560 of 581) with videos related to
Page
of 59
Sort By:
Elife
|
March 30, 2019
Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma
Jianing Xu, Ed Reznik, Ho-Joon Lee, et al.
Clinical Genitourinary Cancer
|
June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
Min Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
JCO Precision Oncology
|
November 9, 2020
Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis Pairs
Michael L Cheng, Mark T A Donoghue, François Audenet, et al.
JCO Precision Oncology
|
June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype
Nima Almassi, Karissa Whiting, Antoun Toubaji, et al.
Genome Biology
|
November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
European Urology
|
May 18, 2017
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies
Melvin L K Chua, Winnie Lo, Melania Pintilie, et al.
European Urology
|
April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
Carissa E Chu, Ziyu Chen, Karissa Whiting, et al.
Journal of the American Medical Informatics Association : JAMIA
|
July 14, 2021
Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center
Peter J Schüffler, Luke Geneslaw, D Vijay K Yarlagadda, et al.
International Journal of Antimicrobial Agents
|
March 15, 2023
LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoring
Cindy Lau, Deborah Marriott, Jessica Bui, et al.
Carcinogenesis
|
May 19, 2010
Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers
Sungshim L Park, Delara Bastani, Binh Y Goldstein, et al.
Page
of 59
Search research articles
Search
Showing results (551-560 of 581) with videos related to
Sort By:
Page
of 59
Elife
|
March 30, 2019
Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma
Jianing Xu, Ed Reznik, Ho-Joon Lee, et al.
Clinical Genitourinary Cancer
|
June 8, 2022
Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy
Min Yuen Teo, Brendan J Guercio, Arshi Arora, et al.
JCO Precision Oncology
|
November 9, 2020
Germ Cell Tumor Molecular Heterogeneity Revealed Through Analysis of Primary and Metastasis Pairs
Michael L Cheng, Mark T A Donoghue, François Audenet, et al.
JCO Precision Oncology
|
June 22, 2022
Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype
Nima Almassi, Karissa Whiting, Antoun Toubaji, et al.
Genome Biology
|
November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
European Urology
|
May 18, 2017
A Prostate Cancer "Nimbosus": Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies
Melvin L K Chua, Winnie Lo, Melania Pintilie, et al.
European Urology
|
April 27, 2025
Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma
Carissa E Chu, Ziyu Chen, Karissa Whiting, et al.
Journal of the American Medical Informatics Association : JAMIA
|
July 14, 2021
Integrated digital pathology at scale: A solution for clinical diagnostics and cancer research at a large academic medical center
Peter J Schüffler, Luke Geneslaw, D Vijay K Yarlagadda, et al.
International Journal of Antimicrobial Agents
|
March 15, 2023
LInezolid Monitoring to MInimise Toxicity (LIMMIT1): A multicentre retrospective review of patients receiving linezolid therapy and the impact of therapeutic drug monitoring
Cindy Lau, Deborah Marriott, Jessica Bui, et al.
Carcinogenesis
|
May 19, 2010
Associations between NBS1 polymorphisms, haplotypes and smoking-related cancers
Sungshim L Park, Delara Bastani, Binh Y Goldstein, et al.
Page
of 59